| Michigan Senate votes to outlaw female genital mutilation | | | (Reuters) - The Michigan Senate approved legislation on Wednesday making genital mutilation of girls a state felony punishable by up to 15 years in prison, both for doctors who perform the procedure and parents who transport a child to undergo the surgery. |
| |
| Pfizer drug from Medivation deal shows promise in breast cancer: study | | | (Reuters) - A breast cancer drug that Pfizer Inc acquired with its $14 billion purchase of Medivation showed promising anti-tumor activity following prior treatments and a modest ability to hold the disease in check, according to data from a mid-stage study released on Wednesday. |
| |
| Bayer gets FDA priority review for blood cancer drug | | | FRANKFURT, Germany (Reuters) - German drugmaker Bayer won the U.S. Food and Drug Administration's priority review status for an experimental drug for a difficult to treat type of blood cancer, bolstering its development pipeline. |
| |
| Celgene leukemia drug extends survival in early stage trial | | | (Reuters) - Nearly 20 percent of patients with an aggressive form of leukemia experienced complete remission along with prolonged survival from treatment with an experimental Celgene Corp drug, according to data from an early-stage study released on Wednesday. |
| |
| Merck, Incyte immunotherapy combination effective in lung cancer study | | | (Reuters) - A combination of the Merck & Co immunotherapy Keytruda and a different type of drug that also helps the immune system fight cancer from Incyte Corp led to a high rate of durable responses in a small, ongoing study of patients with advanced lung cancer, according to data released on Wednesday. |
| |
| ImmunoGen drug moving ahead in single-agent, combination trials | | | (Reuters) - Latest results from a mid-stage trial of ImmunoGen Inc's experimental antibody-drug conjugate show that it shrinks or stabilizes tumors in nearly half of advanced ovarian cancer patients with at least medium levels of a key biomarker whose disease has become resistant to standard chemotherapy. |
| |
| | |
